GSE207376 GSE207377 nutlin-3 3 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207376_GSE207377_nutlin-3_3_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207376_GSE207377_nutlin-3_3_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207376_GSE207377_nutlin-3_3_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207376_GSE207377_nutlin-3_3_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

BAIAP2 divergent transcript

Gene

DPPA2 upstream binding RNA

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

MAGI2 antisense RNA 3

Gene

PSMG3 antisense RNA 1

Gene

NIPBL divergent transcript

Gene

TGF-beta induced TARBP2 interacting lncRNA

Gene

long intergenic non-protein coding RNA 472

Gene

uncharacterized LOC643977

Gene

MBNL1 antisense RNA 1

  • Gene

    BAIAP2 divergent transcript


  • Gene

    DPPA2 upstream binding RNA


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    PSMG3 antisense RNA 1


  • Gene

    NIPBL divergent transcript


  • Gene

    TGF-beta induced TARBP2 interacting lncRNA


  • Gene

    long intergenic non-protein coding RNA 472


  • Gene

    uncharacterized LOC643977


  • Gene

    MBNL1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.